Holen Sie sich die Stockscreener-App
42.33
2.44%
-1.0718
Schlusskurs vom Vortag:
$43.40
Offen:
$42.41
24-Stunden-Volumen:
259.57K
Relative Volume:
0.41
Marktkapitalisierung:
$768.53M
Einnahmen:
$116.88M
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-302.34
EPS:
-0.14
Netto-Cashflow:
$-20.74M
1W Leistung:
-4.66%
1M Leistung:
+20.32%
6M Leistung:
+93.78%
1J Leistung:
+82.82%
1-Tages-Spanne:
$42.10
$44.46
1-Wochen-Bereich:
$39.60
$49.96
52-Wochen-Spanne:
$14.63
$52.24
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Firmenname
Rigel Pharmaceuticals
Sektor
Branche
Telefon
650-624-1100
Adresse
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RIGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
42.34 | 787.77M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.48 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.65 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.28 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.79 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.49 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-05 | Hochstufung | Jefferies | Hold → Buy |
| 2023-04-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-06-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | Eingeleitet | B. Riley Securities | Neutral |
| 2020-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-11-15 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-09-26 | Fortgesetzt | JP Morgan | Overweight |
| 2019-03-01 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-08-27 | Eingeleitet | Citigroup | Buy |
| 2018-05-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-11-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-31 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-30 | Bestätigt | Piper Jaffray | Overweight |
| 2016-07-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-04-22 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2013-04-08 | Bestätigt | Stifel | Buy |
| 2012-11-29 | Eingeleitet | UBS | Neutral |
| 2012-11-06 | Bestätigt | Oppenheimer | Outperform |
| 2012-03-26 | Eingeleitet | Canaccord Genuity | Hold |
| 2010-12-10 | Herabstufung | MP Advisors | Outperform → Market Perform |
Alle ansehen
Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten
Rigel Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 13.7%Should You Sell? - MarketBeat
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Rigel Pharmaceuticals (RIGL) Shares Promising Data from Phase 1b Study - GuruFocus
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891 - TipRanks
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition - PR Newswire
How the Narrative Surrounding Rigel Pharmaceuticals Is Shifting After Upgraded Targets and Guidance - Yahoo Finance
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Why Rigel Pharmaceuticals Inc. (RI2) stock could break out in 2025July 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Is Rigel Pharmaceuticals Inc. (RI2) stock supported by free cash flowTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Will Rigel Pharmaceuticals Inc. (RI2) stock split increase liquidityWeekly Trade Review & Free High Accuracy Swing Entry Alerts - Newser
Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Year in Review & Verified Stock Trade Ideas - Newser
Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueMarket Sentiment Report & AI Based Trade Execution Alerts - Newser
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - sharewise.com
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 6.1%Time to Sell? - MarketBeat
Will Rigel Pharmaceuticals Inc. (RI2) stock outperform small cap peers2025 Market Overview & Weekly High Potential Stock Alerts - Newser
Can Rigel Pharmaceuticals Stock Recover If Markets Fall? - Trefis
(RIGL) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Is Rigel Pharmaceuticals Inc. (RI2) stock a top dividend aristocrat candidatePortfolio Performance Report & Long-Term Investment Growth Plans - Newser
Is Rigel Pharmaceuticals Inc. (RI2) stock a buy before new product rolloutWeekly Market Summary & Stock Market Timing Techniques - Newser
Rigel Pharmaceuticals (RIGL) Stock Analysis Report | Financials & Insights - Benzinga
Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleTake Profit & Long-Term Capital Growth Strategies - Newser
Is Rigel Pharmaceuticals Inc. stock a buy for dividend growthMarket Performance Summary & Verified Technical Signals - Newser
What analysts say about Rigel Pharmaceuticals Inc RI2 stockVolume Analysis Techniques & Accelerated Financial Growth - earlytimes.in
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress
Is Rigel Pharmaceuticals Inc. stock near bottom after decline2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn
Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - sharewise.com
Rigel Pharmaceuticals Inc RI2 Stock Analysis and ForecastSmall Cap Stock Opportunities & Discover Your Financial Freedom Formula - earlytimes.in
If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st
Dynamic Technology Lab Private Ltd Sells 13,113 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals (RIGL) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals (NASDAQ:RIGL) Hits New 52-Week HighTime to Buy? - MarketBeat
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Institutional Investors Control 85% of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and Were Rewarded Last Week After Stock Increased 10% - 富途牛牛
Rigel Stock Surges on Upward Earnings Revisions - Ad-hoc-news.de
LSV Asset Management Buys Shares of 95,700 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
How Recent Developments Are Rewriting the Story for Rigel Pharmaceuticals - Yahoo Finance
Rigel Pharmaceuticals, Inc.Common Stock (Nasdaq:RIGL) Stock Quote - Markets Financial Content
RIGLRigel Pharmaceuticals Stock Price and Quote - Finviz
How Rigel Pharmaceuticals Inc. (RI2) stock stacks up against competitorsJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
How Rigel Pharmaceuticals Inc. (RI2) stock benefits from digital adoptionOptions Play & Daily Profit Focused Stock Screening - newser.com
Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - MSN
Rigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial - MSN
How Rigel Pharmaceuticals Inc. (RI2) stock trades in high volatilityTrade Entry Summary & Breakout Confirmation Trade Signals - newser.com
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 8%Here's What Happened - MarketBeat
Will Rigel Pharmaceuticals Inc. stock reach Wall Street targets2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
What insider trading reveals about Rigel Pharmaceuticals Inc. stock2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Measuring Rigel Pharmaceuticals Inc.’s beta against major indices2025 Performance Recap & Verified Trade Idea Suggestions - newser.com
Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):